MDLinx Conference Coverage – July 2016

The MDLinx editors covered 4 interesting medical conferences during the month of July with a focus on dermatology, AIDS, ENT, cancer, and gastrointestinal cancer. Some of the highlights follow. As reported at the ESMO 18th World Congress on Gastrointestinal Cancer held in Barcelona, Spain, June 29–July 2 July, anti-IL-1α antibody is effective in patients with metastatic colorectal cancer who have failed standard therapy (oxaliplatin and irinotecan). Patients treated with anti-IL-1α monoclonal antibody (n=207) had a 33% treatment responsecompared with 19% in patients treated with placebo. There was also a 26% relative risk reduction in adverse events. Use of a free […]

See What You Missed at the June Medical Conferences

In the month of June, the MDLinx editors covered a number of interesting conferences in a number of specialties, including neurology, oncology, rheumatology, and endocrinology. Here are some of the studies that were presented at those conferences. The 2016 Annual Meeting of the Consortium of Multiple Sclerosis Centers was held in Baltimore, MD June 1-4, 2016. The OPERA I and II investigators presented findings on the effect of ocrelizumab (OCR), an anti-CD20+ B cell monoclonal antibody, on specific humoral immunity in two identical phase 3, randomized, double-blind, double-dummy, interferon beta-1a (IFNβ-1a)-controlled trials involving patients with relapsing multiple sclerosis. The article […]

MDLinx Conference Coverage – May 2016

The MDLinx editors had a busy month in May, covering a total of 11 medical conferences with a focus on endocrinology, oncology, gastroenterology, psychiatry, obstetrics & gynecology, pulmonology, pain, urology, and ophthalmology. Here is a review of some of the highlights. The 41st Annual Congress of Oncology Nursing Society met in San Antonio, TX April 28–May 1. In one study, rolapitant (180 mg 1-2 h before chemotherapy), a neurokinin-1 receptor antagonist, was shown to reduce nausea in patients receiving cisplatin- and carboplatin-based chemotherapy, and thus improve quality of life. The 13th International Conference on Obesity was held in Vancouver, British […]

What conferences did you miss in March? The latest on the better chemotherapy, weekend mortality rates, peanut allergy, and more.

In March, MDLinx editors covered a number of interesting and cutting edge conferences, including women’s cancer, hospital medicine, allergy, dermatology, and orthopedic surgery. Here are some of the studies you might have missed. As reported at the 47th Annual Meeting of the Society of Gynecologic Oncology on Women’s Cancer in San Diego, CA (March 19-22, 2016), Joan L. Walker, MD, from the Stephenson Cancer Center Gynecologic Cancers Clinic at Oklahoma University, Oklahoma City, found that compared with intravenous chemotherapy, intraperitoneal chemotherapydoes not improve progression-free survival (PFS) in women with stage II and III ovarian, fallopian tube, or peritoneal carcinoma who have […]

What conferences did you miss in February? Review them here.

In the last month, MDLinx editors covered a number of interesting and cutting edge conferences, including those on retroviruses and opportunistic infections, critical care medicine, pain medicine, multiple sclerosis, rheumatology, and stroke. Highlights of some of these conferences are described here. As reported at the 23rd Conference on Retroviruses and Opportunistic Infections, which was held in Boston, MA, February 22-25, between 2004 and 2010, the percentage of HIV-positive patients who were screened for Neisseria (NG) and Chlamydia (CT) increased from 22% to 39%. “As NG/CT testing increased, the test positivity also increased, yielding an overall improvement in case detection in […]

See What You Missed at December Medical Conferences

In the last month, MDLinx editors covered a number of interesting and cutting edge conferences in a number of specialties, including hematology, medical oncology, and breast cancer. Here are some of the highlights. The 57th American Society of Hematology Annual Meeting & Exposition (ASH) was held in Orlando, FL, December 5-8, 2015. Dietger Niederwieser, MD, of the University of Leipzig in Leipzig, Germany, reported that younger patients with acute myeloid leukemia (AML) had more favorable molecular markers than the elderly counterparts. There was a similar distribution of cytogenetic risk in both groups (favorable: 12% in both age groups, intermediate: 66% […]

See What You Missed at the November Medical Conferences

During the month of November, MDLinx editors covered a number of interesting conferences in a number of specialties, including dermatology, ophthalmology, hepatology, cardiology, nephrology, allergy & immunology, and weight disorders. Some highlights follow: The 12th International Congress of the Society for Melanoma Research met in San Francisco, CA November 18-21. Professor Axel Hauschild of University Hospital Schleswig-Holstein reported the results of a study involving patients with BRAFV600 mutation-positive melanoma treated with vemurafenib. According to Dr. Hauschild, “…patients with prognostic factors associated with stable disease status, including a lack of brain metastases, normal LDH levels, and lower M stage, had longer PFS […]

Review the latest studies from the October medical conferences that you missed

During October, the MDLinx editors covered a number of interesting conferences in a number of specialties, including pediatrics, gastroenterology, child and adolescent psychiatry, radiation oncology, neurology, cardiology, optometry, and infectious diseases. Some highlights follow: The annual meeting of the American Academy of Optometry was held in New Orleans, LA, October 1-10. According to Kristen Reinard, OD, of Midwestern University Arizona College of Optometry, “Systemic HDL levels have an effect on the health of corneal nerves in patients with and without diabetes.” The number and density of corneal nerves were measured in the study and the researchers found that higher levels […]

See What You Missed at the September Medical Conferences

In the last month, MDLinx editors covered a number of interesting and cutting edge conferences in a number of specialties, including cardiology, endocrinology, neurology, oncology, pulmonology, and several others. At the 16th World Conference on Lung Cancer, which took place in Denver, CO, there were a number of interesting presentations, including one on drug regulatory delays, presented by David Stewart, MD, FRCPC, from the University of Ottawa/The Ottawa Hospital in Ottawa, Canada, that looked at how the regulatory process slows progress by increasing drug development costs and produces hindrances that delay approval of useful drugs. Another presentation, by Eric Lim, […]